EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neobavaisoflavone Ameliorates Memory Deficits and Brain Damage in Aβ 25‐35 ‐Induced Mice by Regulating SIRT1

Fengxiao Hao, Mengnan Zeng, Bing Cao, Xiwen Liang, Kaili Ye, Xinmian Jiao, Weisheng Feng, Xiaoke Zheng iD

CNS Neuroscience & Therapeutics · 2024

DOI: 10.1111/cns.70068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Fengxiao Hao und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, China. Hauptthemen laut MEDLINE: Sirtuin 1, Memory Disorders, Amyloid beta-Peptides, Peptide Fragments. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Henan Provincial High-level Talents Special Support "Zhongyuan Thousand Talents Plan"-Zhongyuan Leading Talents, National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alzheimer's disease (AD) is a common chronic neurodegenerative disease in older people, and there is no specific treatment that can stop or reverse its progression. Neobavaisoflavone (NBIF) is a flavonoid that has been shown to have neuroprotective effects, but its role in AD has not been revealed. The present study investigated the role and mechanism of NBIF on Aβ 25‐35 ‐induced brain injury.

Methods

In this experiment, the AD mouse model was established by injection of Aβ 25‐35 peptides (200 μM, icv), and Donepezil (Don, 10 mg/kg/days), NBIF‐L (15 mg/kg/days), and NBIF‐H (30 mg/kg/days) were administered orally for 4 weeks. Learning memory, hippocampal pathological changes, pathological markers, apoptosis, oxidative stress, inflammation, immune cells were measured in mice. Network pharmacology combined with the GEO database led to the identification of SIRT1, a key target for NBIF intervention in AD, and levels of SIRT1, p‐STAT3 and FOXO1 were measured. In addition, the antagonistic activity of SIRT1 transfection silencing against NBIF in Aβ 25‐35 ‐induced in N9 cells and N2a‐APP69 cells was investigated to assess whether the effects caused by NBIF were mediated by SIRT1.

Results

The results showed that NBIF ameliorated learning memory and hippocampal neuronal damage, reduced pathological markers, apoptosis, oxidative stress and neuroinflammation, and modulated immune cells. SIRT1 is a key target for NBIF intervention in AD, and NBIF upregulates SIRT1 and reduces the expression levels of p‐STAT3 and FOXO1. Furthermore, silencing SIRT1 effectively reduced the protective effect of NBIF on Aβ 25‐35 ‐induced N9 cells and N2a‐APP69 cells, which indicated that the protective effect of NBIF on AD is related to SIRT1.

Conclusions

NBIF ameliorated Aβ 25‐35 ‐induced brain injury by inhibiting apoptosis, oxidative stress, and neuroinflammation, which may be mediated through SIRT1 signaling. These findings provide a rationale for NBIF in the treatment of AD and help facilitate the development of clinical therapeutic agents for AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sirtuin 1Memory DisordersAmyloid beta-PeptidesPeptide FragmentsAnimalsMiceMaleNeuroprotective AgentsMice, Inbred C57BLHippocampusOxidative StressFlavonoidsMaze LearningAlzheimer DiseaseApoptosis

Stichwörter der Autor:innen

Alzheimer's diseaseSIRT1brain injuryneobavaisoflavoneneuroinflammationoxidative stress

Substanzen

Sirtuin 1Amyloid beta-Peptidesamyloid beta-protein (25-35)Peptide FragmentsSirt1 protein, mouseNeuroprotective AgentsFlavonoids

Autor:innen und Institutionen

  • College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, China.
  • The Engineering and Technology Center for Chinese Medicine Development of Henan Province, Zhengzhou, China.
  • Co-construction Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases by Henan & Education Ministry of P.R, Zhengzhou, China.

ORCID-Profile: Xiaoke Zheng

Förderung

  • Henan Provincial High-level Talents Special Support "Zhongyuan Thousand Talents Plan"-Zhongyuan Leading Talents
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Hao, F., Zeng, M., Cao, B., Liang, X., Ye, K., Jiao, X., Feng, W., & Zheng, X. (2024). Neobavaisoflavone Ameliorates Memory Deficits and Brain Damage in Aβ 25‐35 ‐Induced Mice by Regulating SIRT1. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70068

Vancouver

Hao F, Zeng M, Cao B, Liang X, Ye K, Jiao X, et al. Neobavaisoflavone Ameliorates Memory Deficits and Brain Damage in Aβ 25‐35 ‐Induced Mice by Regulating SIRT1. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.70068

BibTeX
@article{Hao2024,
  author = {Hao, Fengxiao and Zeng, Mengnan and Cao, Bing and Liang, Xiwen and Ye, Kaili and Jiao, Xinmian and Feng, Weisheng and Zheng, Xiaoke},
  title = {Neobavaisoflavone Ameliorates Memory Deficits and Brain Damage in Aβ 25‐35 ‐Induced Mice by Regulating SIRT1},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2024},
  doi = {10.1111/cns.70068}
}
Kostenlos starten →